Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03520205 |
Date of registration:
|
15/04/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Quadratus Lumborum Block Versus Epidural for Laparoscopic Nephrectomy Kidney Donor
|
Scientific title:
|
Comparison Between Quadratus Lumborum Block and Epidural on Stress Response and Perioperative Cellular Immunological Function of Laparoscopic Nephrectomy Kidney Donor |
Date of first enrolment:
|
May 1, 2018 |
Target sample size:
|
62 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03520205 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Investigator).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Indonesia
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Kidney donor patients undergoing laparoscopic nephrectomy
- Body mass index below 30
- Duration of surgery 4 to 6 hours
- Patients who agreed to participate in this study and sign informed consent.
Exclusion Criteria:
Have contraindication for quadratus lumborum block
- Have contraindication for epidural
- Previous history of local anesthetic drug allergy
- inability to communicate
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Renal Transplant Donor of Left Kidney
|
Intervention(s)
|
Procedure: Quadratus Lumborum Block
|
Procedure: Continuous Epidural
|
Primary Outcome(s)
|
Cumulative morphine requirement at 2 hours, 6 hours, 12 hours, 24 hours postoperative
[Time Frame: 2 hours, 6 hours, 12 hours, 24 hours.]
|
Change from Baseline Interleukin-6 at 24 hours after abdominal insufflation
[Time Frame: Before procedure, at the end of surgery, and 24 hours after abdominal insufflation]
|
Secondary Outcome(s)
|
Change from Baseline Mean Arterial Pressure
[Time Frame: Intraoperative and 24 hours]
|
Number of participants with paresthesia after procedure
[Time Frame: 24 hours]
|
Change from Baseline Blood pressure
[Time Frame: Intraoperative and 24 hours]
|
Change from Baseline Cardiac Index
[Time Frame: Intraoperative and 24 hours]
|
Change from baseline motor block at 2, 6, 12, and 24 hours after anesthesia recovery
[Time Frame: 2, 6, 12, and 24 hours after procedure]
|
Level of sensory block after procedure
[Time Frame: 24 hours]
|
Total bupivacaine used in 24 hours
[Time Frame: 24 hours]
|
Change from Baseline Pain Intensity at 2, 6, 12, and 24 hours after procedure
[Time Frame: 2, 6, 12, and 24 hours after procedure]
|
Time to first morphine requirement
[Time Frame: 24 hours]
|
Change from Baseline Blood Glucose at 2 hours after abdominal insufflation
[Time Frame: Before procedure and 2 hours after abdominal insufflation]
|
Change from Baseline Heart Rate
[Time Frame: Intraoperative and 24 hours]
|
Change from Baseline Patient Controlled Analgesia at 2, 6, 12 and 24 hours after procedure
[Time Frame: 2, 6, 12, and 24 hours after procedure]
|
Duration of urinary catheter
[Time Frame: 24 hours]
|
Change from Baseline hs-CRP at 48 hours after abdominal insufflation
[Time Frame: Before procedure, at the end of surgery, and 48 hours after abdominal insufflation]
|
Secondary ID(s)
|
IndonesiaUAnes021
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|